| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/05/2012 | US20120003232 Use of antibodies for the vaccination against cancer |
| 01/05/2012 | US20120003231 Cell surface molecule mediating cell adhesion and signal transmission |
| 01/05/2012 | US20120003226 Methods for treating or preventing il-1beta related diseases |
| 01/05/2012 | US20120003225 Autoantibodies in the detection and treatment of cancer |
| 01/05/2012 | US20120003224 ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2 |
| 01/05/2012 | US20120003216 Fgf21 mutants and uses thereof |
| 01/05/2012 | US20120003214 Binding Moieties Based On Shark IgNAR Domains |
| 01/05/2012 | US20120003211 Immunoglobulins with reduced aggregation |
| 01/05/2012 | US20120003210 NEONATAL Fc RECEPTOR (FcRn)- BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| 01/05/2012 | US20120003208 Compositions and methods for modulating vascular development |
| 01/05/2012 | US20120003157 Use of anti-90k monoclonal antibodies for the prevention and treatment of tumors and metastases thereof |
| 01/05/2012 | US20120003149 Novel monoclonal antibody, and use thereof |
| 01/05/2012 | CA2803937A1 Reagents and methods for diagnosing conditions associated with hydroxylated hif 1-a |
| 01/05/2012 | CA2803298A1 Compositions and methods related to protein a (spa) variants |
| 01/05/2012 | CA2803234A1 Histone citrullinated peptides and uses thereof |
| 01/05/2012 | CA2799472A1 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 01/04/2012 | EP2402762A1 Chloral hydrate immunoassay |
| 01/04/2012 | EP2402761A1 Chloral hydrate detection |
| 01/04/2012 | EP2402756A2 Agonist anti-trkC antibodies and methods using same |
| 01/04/2012 | EP2402444A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 01/04/2012 | EP2402374A1 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 01/04/2012 | EP2402373A2 Anti-EphB4 Antibodies and Methods Using Same |
| 01/04/2012 | EP2402372A2 Therapeutic agent |
| 01/04/2012 | EP2402371A1 Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof |
| 01/04/2012 | EP2402370A1 Novel antibody for the diagnosis and/or prognosis of cancer |
| 01/04/2012 | EP2402368A1 Histone citrullinated peptides and uses thereof |
| 01/04/2012 | EP2402365A1 Crystal structure of amino terminal portion of influenza virus polymerase pa subunit and use thereof |
| 01/04/2012 | EP2402359A1 Recombinant protective protein from streptococcus pneumoniae |
| 01/04/2012 | EP2402033A1 Cell adhesion inhibitor and use thereof |
| 01/04/2012 | EP2402030A1 Linear IgE peptide epitopes of celery allergen api 1 |
| 01/04/2012 | EP2402016A1 Aptamers that inhibit interaction between antibody and 1st or 2nd extracellular loop of human beta-1-adrenergic receptor |
| 01/04/2012 | EP2401618A2 Methods for determine atherosclerosis regression, plaque stabilization and cardiovascular risk |
| 01/04/2012 | EP2401378A2 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris |
| 01/04/2012 | EP2401302A1 Antibodies containing therapeutic tpo/epo mimetic peptides |
| 01/04/2012 | EP2401300A1 ANTI-C mX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES |
| 01/04/2012 | EP2401299A1 Anti-icam-1 antibody, uses and methods |
| 01/04/2012 | EP2401298A1 Antigen-binding constructs |
| 01/04/2012 | EP2401297A1 Antigen-binding constructs |
| 01/04/2012 | EP2401296A1 Multivalent and/or multispecific rankl-binding constructs |
| 01/04/2012 | EP2401295A1 Method for producing antibodies |
| 01/04/2012 | EP2401294A1 Method for producing antibodies |
| 01/04/2012 | EP2401292A1 Antibodies to troponin i and methods of use thereof |
| 01/04/2012 | EP2401035A1 Antibodies specifically directed to the soluble form of ctla-4 |
| 01/04/2012 | EP2400984A1 Her2 antibody compositions |
| 01/04/2012 | EP2400981A1 Humanized platelet activating factor antibody design using anti-lipid antibody templates |
| 01/04/2012 | EP2046831B1 Novel multivalent immunoglobulins |
| 01/04/2012 | EP1080107B1 Novel peptides which represent the epitopes of the human herpes virus type 8 |
| 01/04/2012 | CN1944460B Alr polypeptide and application thereof |
| 01/04/2012 | CN102308216A Immunoglobulin glycosylation pattern analysis |
| 01/04/2012 | CN102307905A Production of carrier-peptide conjugates using chemically reactive unnatural amino acids |
| 01/04/2012 | CN102307902A Amino acid sequenes directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis |
| 01/04/2012 | CN102307901A Binding members against IL-1R1 |
| 01/04/2012 | CN102307900A Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof |
| 01/04/2012 | CN102307899A Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune and cardiovascular disorders |
| 01/04/2012 | CN102307898A Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent |
| 01/04/2012 | CN102307897A Methods for selecting protease resistant polypeptides |
| 01/04/2012 | CN102305855A Reagent and method for detecting Mycobacterium tuberculosis infection in vitro |
| 01/04/2012 | CN102304527A Enterococcus antigens |
| 01/04/2012 | CN102304493A Monoclonal antibody against riemerella anatipestifer (RA) |
| 01/04/2012 | CN102304184A Neuropilin antagonists |
| 01/04/2012 | CN102304183A Preparation of aspergillus galactomannan monoclonal antibody and prepared product |
| 01/04/2012 | CN102304182A Preparation method and use of enterotoxigenic Escherichia coli egg yolk antibody powder |
| 01/04/2012 | CN102304181A Monoclonal antibody of avian leukosis virus subgroup J surface protein and preparation method thereof |
| 01/04/2012 | CN102304180A Monoclonal antibody of avian reticuloendotheliosis virus envelope protein and preparation method thereof |
| 01/04/2012 | CN102302777A Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases |
| 01/04/2012 | CN101792738B Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof |
| 01/04/2012 | CN101791405B Method for preparing yolk immunoglobulin vaccine for resisting porphyromonas gingivalis |
| 01/04/2012 | CN101717775B Single-chain antibody gene of anti-human death receptor 5 |
| 01/04/2012 | CN101580545B Monoclonal antibody of hemagglutinin protein resisting H5N1 resource and application thereof |
| 01/04/2012 | CN101357942B Monoclonal antibody, Fab antibody and application for neutralizing enterohemorrhagic escherichia coli o157:H7 shiga toxin II |
| 01/04/2012 | CN101273134B Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes and method |
| 01/04/2012 | CN101060931B Antibodies by chromatography |
| 01/04/2012 | CN101018863B Mutant pneumolysin proteins |
| 01/03/2012 | US8088974 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 01/03/2012 | US8088909 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 01/03/2012 | US8088905 Nucleic acids encoding antibodies against PD-1 |
| 01/03/2012 | US8088900 Two-phase precipitation of proteins |
| 01/03/2012 | US8088898 Therapeutic use of anti-CS1 antibodies |
| 01/03/2012 | US8088897 Detecting the activity of and screening acceptor substrates, inhibitors, or activators of enzymes catalyzing group transfer reactions to facilitate the development of more selective and therapeutic drugs |
| 01/03/2012 | US8088896 Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38 |
| 01/03/2012 | US8088895 Antibodies that bind CXCR7 epitopes |
| 01/03/2012 | US8088893 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 01/03/2012 | US8088890 Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/03/2012 | US8088887 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 01/03/2012 | US8088886 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/03/2012 | US8088833 Method for purifying an IgG monomer |
| 01/03/2012 | US8088618 Anti-IL 13 antibodies and uses thereof |
| 01/03/2012 | US8088617 Antibodies that bind the glutamate ligand binding region of Notch1 |
| 01/03/2012 | US8088609 amino acid sequence of antibodies and nucleotide sequences that code for the polypeptides; antibody-directed enzyme prodrug therapy (ADEPT) constructs directed against carcinoembryonic antigen (CEA); tissue-targeted therapy |
| 01/03/2012 | US8088588 Genetic products differentially expressed in tumors and the use of thereof |
| 01/03/2012 | US8088569 Immunogens for treatment of neoplastic and infectious disease |
| 01/03/2012 | US8088390 Methods for the early diagnosis of ovarian cancer |
| 01/03/2012 | US8088384 Anti-NGF antibodies and methods using same |
| 01/03/2012 | US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
| 01/03/2012 | US8088380 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 01/03/2012 | US8088379 Modified T cell receptors and related materials and methods |
| 01/03/2012 | US8088378 Anti-CD79B antibodies and immunoconjugates and methods of use |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | US8088375 Anti-VEGF antibody |
| 01/03/2012 | US8088374 Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists |